These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 21594629)

  • 1. Cardiac resynchronization therapy in patients with mild heart failure: a systematic review and meta-analysis.
    Santangeli P; Di Biase L; Pelargonio G; Dello Russo A; Casella M; Bartoletti S; Burkhardt JD; Mohanty P; Santarelli P; Natale A
    J Interv Card Electrophysiol; 2011 Nov; 32(2):125-35. PubMed ID: 21594629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac resynchronization therapy in patients with minimal heart failure: a systematic review and meta-analysis.
    Adabag S; Roukoz H; Anand IS; Moss AJ
    J Am Coll Cardiol; 2011 Aug; 58(9):935-41. PubMed ID: 21851882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.
    Linde C; Abraham WT; Gold MR; St John Sutton M; Ghio S; Daubert C;
    J Am Coll Cardiol; 2008 Dec; 52(23):1834-1843. PubMed ID: 19038680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
    Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of cardiac resynchronization therapy in mild congestive heart failure: systematic review and meta-analysis of randomized trials.
    Lubitz SA; Leong-Sit P; Fine N; Kramer DB; Singh J; Ellinor PT
    Eur J Heart Fail; 2010 Apr; 12(4):360-6. PubMed ID: 20335354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
    Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
    De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
    J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.
    Abraham WT; Young JB; León AR; Adler S; Bank AJ; Hall SA; Lieberman R; Liem LB; O'Connell JB; Schroeder JS; Wheelan KR;
    Circulation; 2004 Nov; 110(18):2864-8. PubMed ID: 15505095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Extrapolation of Clinical Benefits Among Patients With Mild Heart Failure Receiving Cardiac Resynchronization Therapy: Analysis of the 5-Year Follow-Up From the REVERSE Study.
    Gold MR; Padhiar A; Mealing S; Sidhu MK; Tsintzos SI; Abraham WT
    JACC Heart Fail; 2015 Sep; 3(9):691-700. PubMed ID: 26277764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A systematic review and meta-analysis on efficacy and safety of cardiac resynchronization therapy alone or in combination with implantable cardioversion defibrillation in patients with mild to severe heart failure].
    Tu RH; Peng RL; Zhong GQ; Wu WF; Chen L; Liang YY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Feb; 41(2):161-70. PubMed ID: 23710749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I/II heart failure.
    St John Sutton M; Ghio S; Plappert T; Tavazzi L; Scelsi L; Daubert C; Abraham WT; Gold MR; Hassager C; Herre JM; Linde C;
    Circulation; 2009 Nov; 120(19):1858-65. PubMed ID: 19858419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left Ventricular Architecture, Long-Term Reverse Remodeling, and Clinical Outcome in Mild Heart Failure With Cardiac Resynchronization: Results From the REVERSE Trial.
    St John Sutton M; Linde C; Gold MR; Abraham WT; Ghio S; Cerkvenik J; Daubert JC;
    JACC Heart Fail; 2017 Mar; 5(3):169-178. PubMed ID: 28254122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac resynchronization therapy in patients with mild heart failure: a systematic review and meta-analysis of randomized controlled trials.
    Tu R; Zhong G; Zeng Z; Wu W; Wu H; Cao X; Aung LH
    Cardiovasc Drugs Ther; 2011 Aug; 25(4):331-40. PubMed ID: 21750900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry).
    Landolina M; Lunati M; Gasparini M; Santini M; Padeletti L; Achilli A; Bianchi S; Laurenzi F; Curnis A; Vincenti A; Valsecchi S; Denaro A;
    Am J Cardiol; 2007 Sep; 100(6):1007-12. PubMed ID: 17826388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure.
    Linde C; Daubert C; Abraham WT; St John Sutton M; Ghio S; Hassager C; Herre JM; Bergemann TL; Gold MR;
    Circ Heart Fail; 2013 Nov; 6(6):1180-9. PubMed ID: 24014828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cardiac resynchronization therapy outcomes in patients with New York Heart Association functional class I/II versus III/IV heart failure.
    Bank AJ; Rischall A; Gage RM; Burns KV; Kubo SH
    J Card Fail; 2012 May; 18(5):373-8. PubMed ID: 22555266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of reverse remodeling on long-term survival in mildly symptomatic patients with heart failure receiving cardiac resynchronization therapy: results of the REVERSE study.
    Gold MR; Daubert C; Abraham WT; Ghio S; St John Sutton M; Hudnall JH; Cerkvenik J; Linde C
    Heart Rhythm; 2015 Mar; 12(3):524-530. PubMed ID: 25460860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Size Matters: Normalization of QRS Duration to Left Ventricular Dimension Improves Prediction of Long-Term Cardiac Resynchronization Therapy Outcome.
    Zweerink A; Friedman DJ; Klem I; van de Ven PM; Vink C; Biesbroek PS; Hansen SM; Emerek K; Kim RJ; van Rossum AC; Atwater BD; Nijveldt R; Allaart CP
    Circ Arrhythm Electrophysiol; 2018 Dec; 11(12):e006767. PubMed ID: 30541355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New York Heart Association functional class, QRS duration, and survival in heart failure with reduced ejection fraction: implications for cardiac resychronization therapy.
    Braunschweig F; Linde C; Benson L; Ståhlberg M; Dahlström U; Lund LH
    Eur J Heart Fail; 2017 Mar; 19(3):366-376. PubMed ID: 27338764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.